These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22983246)

  • 1. [Pharmacotherapy of epilepsy: the use of topiramate in initial and additional treatment].
    Rudakova IG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6 Pt 2):58-64. PubMed ID: 22983246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The efficacy of topiramate (topamax) in the treatment of resistant epilepsy in children].
    Dorofeeva MIu; Ermakov AIu; Belousova ED
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(11):21-3. PubMed ID: 16329630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacy clinics. Medication of the month. Topiramate (Topamax)].
    Sadzot B
    Rev Med Liege; 2000 Feb; 55(2):114-6. PubMed ID: 10769582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate: a review of its use in the treatment of epilepsy.
    Lyseng-Williamson KA; Yang LP
    Drugs; 2007; 67(15):2231-56. PubMed ID: 17927286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate pharmacokinetics in children and adults with epilepsy: a case-matched comparison based on therapeutic drug monitoring data.
    Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E
    Clin Pharmacokinet; 2005; 44(4):407-16. PubMed ID: 15828853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of topiramate: a review.
    Garnett WR
    Epilepsia; 2000; 41(S1):61-5. PubMed ID: 10768303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age.
    Girgis IG; Nandy P; Nye JS; Ford L; Mohanty S; Wang S; Ochalski S; Eerdekens M; Cox E
    Epilepsia; 2010 Oct; 51(10):1954-62. PubMed ID: 20880232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of topiramate (topamax) in epileptic patients of different age].
    Voronkova KV; Pyleva OA; Petrukhin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(6):34-7. PubMed ID: 16841481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of topiramate.
    Bourgeois BF
    J Child Neurol; 2000; 15 Suppl 1():S27-30. PubMed ID: 11218054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting.
    Guerrini R; Carpay J; Groselj J; van Oene J; Schreiner A; Lahaye M; Schwalen S;
    Seizure; 2005 Sep; 14(6):371-80. PubMed ID: 15961326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate. Clinical profile in epilepsy.
    Sachdeo RC
    Clin Pharmacokinet; 1998 May; 34(5):335-46. PubMed ID: 9592618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of topiramate for the treatment of epilepsy in elderly patients.
    Sommer BR; Fenn HH
    Clin Interv Aging; 2010 Apr; 5():89-99. PubMed ID: 20458347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spotlight on topiramate in epilepsy.
    Lyseng-Williamson KA; Yang LP
    CNS Drugs; 2008; 22(2):171-4. PubMed ID: 18193927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetics of Topiramate in Japanese Pediatric and Adult Patients With Epilepsy Using Routinely Monitored Data.
    Takeuchi M; Yano I; Ito S; Sugimoto M; Yamamoto S; Yonezawa A; Ikeda A; Matsubara K
    Ther Drug Monit; 2017 Apr; 39(2):124-131. PubMed ID: 28230619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of topiramate (Topamax) in epileptic patients of different ages.
    Voronkova KV; Pylaeva OA; Petrukhin AS
    Neurosci Behav Physiol; 2007 Jul; 37(6):547-51. PubMed ID: 17657424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of topiramate pharmacokinetics and tolerability in children with epilepsy.
    Rosenfeld WE; Doose DR; Walker SA; Baldassarre JS; Reife RA
    Pediatr Neurol; 1999 May; 20(5):339-44. PubMed ID: 10371378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic interactions of topiramate.
    Bialer M; Doose DR; Murthy B; Curtin C; Wang SS; Twyman RE; Schwabe S
    Clin Pharmacokinet; 2004; 43(12):763-80. PubMed ID: 15355124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy.
    Langtry HD; Gillis JC; Davis R
    Drugs; 1997 Nov; 54(5):752-73. PubMed ID: 9360061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
    Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
    Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
    Otoul C; De Smedt H; Stockis A
    Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.